eCardio to highlight EMR integration expertise for remote monitoring customers at upcoming conferences

HOUSTON, March 26, 2014  -- eCardio Diagnostics, a leader in remote arrhythmia monitoring services, will highlight its expertise for integrating its services with customers' existing electronic medical records (EMR) systems at upcoming conferences.

For the past four years, eCardio has partnered with hospitals and practices across the nation to integrate the processes and reports associated with remote cardiac monitoring into their established systems in an effort to minimize redundancies and improve speed to diagnosis. Successful integrations have been completed with many of the leading EMR/EHR system providers.

"This has been a focus area of ours for quite some time and has been a key differentiator for us in the industry," said eCardio's Chairman and Chief Executive Officer, Larry Lawson. "We have completed successful integrations with academic medical centers, hospitals, and private practices."

The solutions offered by eCardio are more than just dragging and dropping files from desktops into EMR folders, they provide opportunities for integration at the point of patient enrollment and continue through the final study report, tailored to the customer's need for data. Services include encrypted transmissions and bi-directional or uni-directional data integration. By giving practices several different options, eCardio satisfies the unique requirements of each practice.

eCardio's EMR integrations deliver countless benefits to physicians and their staff. Patients are enrolled quicker because demographic data does not have to be entered multiple times. Clinical reports are accurately placed in patient records eliminating the need for inefficient manual processes and allowing physicians to view the full scope of patient information from a single system.

"We built our reporting portals with a flexible architecture so that we could quickly adapt to the changing needs of our customers. As the requirements for practices to transition into a paperless environment evolve over the next few years, we will be there to meet them," said eCardio's President and Chief Operating Officer, John Untereker.

eCardio has provided remote cardiac monitoring services since 2004, a decade of excellence and counting. 

For more information about eCardio's EMR integration capabilities and the revolutionary eCardio Verite monitor, attendees can visit Booth #2825 next week at ACC.14, the American College of Cardiology's Annual Scientific Session & Expo. eCardio will also participate as an exhibitor at Heart Rhythm 2014 in May.

About eCardio

Headquartered in Houston, Texas, with a second Independent Diagnostic Testing Facility in San Francisco, eCardio Diagnostics, LLC is a leading partner in the delivery of optimal patient care by offering the complete wireless monitoring solution for physicians needing accurate and timely arrhythmia detection in the outpatient setting. Winner of numerous awards from the technology, health, and business sectors, eCardio provides a vast array of products including mobile cardiac telemetry (MCT), as well as looping and non-looping event monitors. The eCardio Verite monitor is a revolutionary single component, dual-mode device that utilizes advanced algorithms to auto-detect arrhythmias and transmit recordings in near, real time to innovative web platforms. Our leading-edge diagnostic innovations and digital solutions, combined with our award-winning Monitoring Center provide physicians and their patients with flexible, fast, and accurate arrhythmia monitoring solutions.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.